Eli Lilly - Any departments feeling the squeeze?

Been seeing some posts about other pharma companies having a tough time lately and it got me thinking about Lilly. No official word or anything concrete, but I've been hearing whispers through the grapevine, mostly about certain R&D areas and maybe some marketing functions. It's vague, and could just be noise, but I figured it was worth putting out there. Anyone in specific departments notice any hiring freezes, budget cuts, or just a general 'weird vibe' lately? Trying to gauge if there's any specific pain point within the company or if it's just general industry anxiety. My team hasn't seen anything, but I'm in a stable area. Just want to prepare myself and others if there's any truth to it. Any intel from those closer to the ground would be appreciated.